Ovarian Cancer Archives - CED Foundation

Should Oncologists Recommend Cannabis?

November 27, 2019 Blood-Levels, Breast Cancer, Cancer, Cannabis, Cannabis Science, Colon Cancer, Endometrial Cancer, Impairment, Ovarian Cancer, Pain, Prostate Cancer, Science, Women in Cannabis

Oncologists Should Recommend Cannabis-Based Medicine for Palliative Care

Oncologists are encouraged to recommend cannabis: cannabis-based medicine for palliative care and more

In Summary:

Earlier this June, a review was published that encourages oncologists to recommend cannabis products to their patients as a safe and effective method of palliative care. The opinion piece highlights how cannabis is a useful treatment for a variety of illnesses (nausea, vomiting, sleep, mood, anxiety), and encourages practitioners to prescribe cannabis for their patients so that they can appreciate the safety and effectiveness of the product.

View this review (yellow link) or download:

Should Oncologists Recommend Cannabis?Download

This paper is also stored here: http://bit.ly/2Dz4UhT inside the CED Foundation Archive

To explore related information, click the keywords below:

Cannabinoids in the treatment of cancer

July 2, 2019 Anti-inflammatory properties, Cancer, Cannabinoids, Cannabis, Cannabis Education, Cannabis Science, Colon Cancer, Dermatology / Skin, Future Medicine, Ovarian Cancer, Prostate Cancer, Science

A literature review from 2009 (10 years ago) summarizes the anti-cancer properties of cannabis, concluding that various cannabinoids might inhibit cancer cell growth and tumor growth. In particular, cannabis shows promise to help treat colon, skin, prostate, and breast cancer.

Cannabinoids-in-the-treatment-of-cancer Download

This paper is also stored here: http://bit.ly/2J1XS8A inside the CED Foundation Archive

To explore related information, click the keywords below:

Cannabidiol May Provide Novel Treatment for Rare Ovarian Cancer

June 27, 2019 Aging, Cancer, Cannabinoids, Cannabis Science, Case Study, CBD, Citizen Science, Elderly, Flavonoids, Future Medicine, Ovarian Cancer, Science, Terpenes

Dramatic response to Laetrile and cannabidiol (CBD) oil in a patient with metastatic low grade serous ovarian carcinoma

A recent case study has examined a patient’s response to the consumption of cannabidiol (CBD) as a treatment for a rare type of ovarian cancer. Rather than participate in chemotherapy, which has been shown to only be effective in 5% of patients with low grade serous ovarian carcinoma, an 81-year-old decided to take a combination of amygdalin and CBD. Although CBD has only been shown to have effective anti-cancer properties in murine models the featured patient reported a significant decrease in tumor size, revealing that CBD may, in fact, be an effective treatment for patients looking into alternative care methods.

Although proven ineffective, the use of amygdalin highlights alternative therapies derived from naturally occurring chemicals found in common plants. Flavonoids and terpenes are chemical components of cannabis plants, also found in a variety of fruits and vegetables, that are just now being investigated for their therapeutic benefits. The results of those inquiries may prove useful for similar patients suffering from illnesses that are resistant to the usual treatments.

View this review (yellow link) or download:

Dramatic response to Laetrile and cannabidiol (CBD) oil in a patient with metastatic low grade serous ovarian carcinoma Download

This paper is also stored here: http://bit.ly/2L9pCJZ inside the CED Foundation Archive

To explore related information, click the keywords below: